Fundraising Fox
/Companies
Sign in

AbInitio Bio

YC X26

Boston, US · Founded 2026 · 2 employees · 6 known investors

Find your way into AbInitio Bio

Sign up to see every warm intro you have to AbInitio Bio

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the AbInitio Bio team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

AbInitio uses AI models to predict molecular properties, optimize bioprocess conditions, and recommend cell line and media selections for biopharmaceutical development. The company serves pharma and biotech teams to accelerate the path from drug candidate to commercial manufacturing scale.

Also known as Ablnitio Bio, Inc.

AI & Machine LearningBiotechHealthtechUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (X26)

AbInitio Bio was founded in 2026 by Daniel Mukasa and Nisha Gopal.

DMDaniel Mukasa
Daniel MukasaFounderDaniel Mukasa holds a PhD in Applied Physics and Materials Science from Caltech and completed postdoctoral work at MIT on AI and drug discovery applications. He previously worked as an AI/ML intern at Merck on antibody therapeutic design, and is now founder and CEO of AbInitio Bio.
NGNisha Gopal
Nisha GopalCo-Founder & CSONisha Gopal holds a PhD in biochemistry from Stanford and brings 14 years of research experience, including prior work as a research scientist at the Broad Institute. She is founder and Chief Scientific Officer of AbInitio Bio.

Investors · 6

BOND STreported

How we know: Y Combinator's founder network · Not right? Tell us

Inflection Point VenturesreportedGurgaon

How we know: Y Combinator's founder network · Not right? Tell us

Milemark Capital PartnersreportedCambridge

How we know: Y Combinator's founder network · Not right? Tell us

Tekedia CapitalreportedLagos · $1K

How we know: Y Combinator's founder network · Not right? Tell us

WefunderreportedSan Francisco

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

bioBIO is the world's largest advocacy association representing biotechnology companies and research institutions across the United States and 30+ other nations. The organization facilitates industry networking through events, conferences, and partnering software while providing cost-savings programs and advocacy services for member companies.
AvidbioAvid Bio provides development and manufacturing services for biologics programs, offering integrated support from early-stage development through commercialization. The company partners with pharmaceutical and biotech teams as a contract development and manufacturing organization (CDMO) with US-based operations.
Actio Biosciences, Inc.Actio is a precision medicine company that translates genetic insights into new therapeutics, developing drugs that target the genes underlying both rare diseases and more prevalent conditions. It focuses on identifying dysregulated gene activity and designing therapies to restore balance and address the root causes of disease.
iBioiBio is a biopharmaceutical company with leadership experienced in drug discovery, development, and clinical operations across multiple therapeutic areas. The company appears to focus on innovative therapeutics and biologics development.
Infinant HealthInfinant Health develops probiotic products based on B. infantis strains that work with breast milk to support the infant gut microbiome, including its INF108 drug strain aimed at preventing necrotizing enterocolitis (NEC) in premature infants. The company operates in the infant health and microbiome therapeutics space.

Companies working in the same space as AbInitio Bio.

Legal entities · 2

corporate structure
AbInitio Bio, Inc.
Ablnitio Bio, Inc.

In the news

AbInitio Bio - Frontier foundation models for biomanufacturingycombinator.com · May 2026

Frequently asked questions

What does AbInitio Bio do?
AbInitio uses AI models to predict molecular properties, optimize bioprocess conditions, and recommend cell line and media selections for biopharmaceutical development. The company serves pharma and biotech teams to accelerate the path from drug candidate to commercial manufacturing scale.
Who founded AbInitio Bio?
AbInitio Bio was founded by Daniel Mukasa, Nisha Gopal in 2026.
Who are AbInitio Bio's investors?
AbInitio Bio's investors include Y Combinator, BOND ST, Inflection Point Ventures, Milemark Capital Partners, Tekedia Capital, Wefunder.
Where is AbInitio Bio headquartered?
AbInitio Bio is headquartered in Boston, US.